A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine
Sponsored by GlaxoSmithKline
About this trial
Last updated 9 years ago
Study ID
776423/001
Status
Completed
Type
Interventional
Phase
Phase 3
Placebo
No
Accepting
10 to 18 Years
All
Trial Timing
Ended 21 years ago
What is this trial about?
This study will evaluate the safety and immune response to GlaxoSmithKline Tdap vaccine
compared to licensed Td vaccine when used as a booster in healthy adolescents (10-18
years of age).
What are the participation requirements?
Inclusion Criteria
- Healthy adolescents with history of completed routine vaccination against diphtheria, tetanus, and pertussis (DTP).
Exclusion Criteria
- Use of any other investigational drug or vaccine 30 days preceding study vaccination.
- Chronic administration of immunosuppressants.
- Administration of pre-school DTP vaccine within previous 5 years.
- Administration of Td booster within previous 10 years.